Humanized Antibody for Treating or Preventing Cognitive Disorders, Process for Producing the Same, and Agent for Treating or Preventing Cognitive Disorders Using the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 15/906,773, filed Feb 27, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,556,950 | Humanized Antibody for Treating or Preventing Cognitive Disorders, Process for Producing the Same, and Agent for Treating or Preventing Cognitive Disorders Using the Same In force · High confidence | Teijin Limited | In force | High confidence | ||
| US 10,894,829 | Humanized Antibody for Treating or Preventing Cognitive Disorders, Process for Producing the Same, and Agent for Treating or Preventing Cognitive Disorders Using the Same In force · High confidence | Teijin Limited | In force | High confidence | ||
| US 11,739,143 | Humanized Antibody for Treating or Preventing Cognitive Disorders, Process for Producing the Same, and Agent for Treating or Preventing Cognitive Disorders Using the Same In force · Low confidence | Teijin Pharma Limited | In force | Low confidence | ||
| Application 14/403,803 | Therapeutic Agent or Prophylactic Agent for Dementia Abandoned Abandoned Jun 13, 2019 | Osaka City University and Teijin Pharma Limited | Abandoned | Abandoned Jun 13, 2019 | ||
| Application 16/436,301 | Therapeutic Agent or Prophylactic Agent for Dementia Abandoned Abandoned Feb 2, 2022 | Osaka City University | Abandoned | Abandoned Feb 2, 2022 | ||
| Application 17/539,926 | Therapeutic Agent or Prophylactic Agent for Dementia Pending Not granted | Osaka City University | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Teijin Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.